down arrow

Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Agri-Seeds
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
153.50
4.9 (3.3%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 7.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Net Sales
332.62
301.36
278.36
Other Operating Income
0.00
0.00
0.00
Total Operating income
332.62
301.36
278.36
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
12.26
5.31
3.56
(Increase) / Decrease In Stocks
-21.16
11.98
4.99
Employee Cost
28.25
23.32
24.78
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
142.47
117.32
115.42
Selling and Distribution Expenses
93.00
70.83
68.38
Other Expenses
27.94
23.86
24.05
Total Expenditure (Excl Depreciation)
282.76
252.62
241.18
Operating Profit (PBDIT) excl Other Income
49.86
48.74
37.18
Other Income
0.63
0.55
1.85
Operating Profit (PBDIT)
50.49
49.29
39.03
Interest
9.11
10.12
10.61
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
41.38
39.17
-60.36
Depreciation
3.26
3.01
3.08
Profit Before Tax
38.12
36.16
-63.43
Tax
1.95
1.15
3.95
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
36.17
35.01
-67.39
Extraordinary Items
3.45
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
39.62
35.01
-67.39
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.02
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.62
35.03
-67.38
Equity Capital
19.00
19.00
19.00
Face Value
10.0
10.0
10.0
Reserves
590.91
554.17
526.94
Earnings per share (EPS)
20.85
18.44
-35.46
Diluted Earnings per share
21.34
18.44
-35.46
Operating Profit Margin (Excl OI)
14.99%
16.17%
13.36%
Gross Profit Margin
12.44%
13.0%
-21.68%
PAT Margin
10.87%
11.62%
-24.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 10.37% vs 8.26% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 13.10% vs 151.99% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 2.30% vs 31.09% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -9.98% vs -4.62% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Nath Bio-Genes With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
332.62
1,148.41
-815.79
-71.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
332.62
1,148.41
-815.79
-71.04%
Raw Material Cost
0.00
592.73
-592.73
-100.00%
Purchase of Finished goods
12.26
0.00
12.26
(Increase) / Decrease In Stocks
-21.16
-12.71
-8.45
-66.48%
Employee Cost
28.25
119.21
-90.96
-76.30%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
142.47
0.00
142.47
Selling and Distribution Expenses
93.00
0.00
93.00
Other Expenses
27.94
163.36
-135.42
-82.90%
Total Expenditure (Excl Depreciation)
282.76
862.59
-579.83
-67.22%
Operating Profit (PBDIT) excl Other Income
49.86
285.82
-235.96
-82.56%
Other Income
0.63
63.21
-62.58
-99.00%
Operating Profit (PBDIT)
50.49
349.03
-298.54
-85.53%
Interest
9.11
0.24
8.87
3,695.83%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
41.38
348.79
-307.41
-88.14%
Depreciation
3.26
28.01
-24.75
-88.36%
Profit Before Tax
38.12
320.77
-282.65
-88.12%
Tax
1.95
20.89
-18.94
-90.67%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
36.17
299.88
-263.71
-87.94%
Extraordinary Items
3.45
0.00
3.45
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
39.62
299.88
-260.26
-86.79%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-1.14
1.14
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.62
298.74
-259.12
-86.74%
Equity Capital
19.00
10.29
8.71
84.65%
Face Value
10.00
2.00
0.00
Reserves
590.91
1,222.41
-631.50
-51.66%
Earnings per share (EPS)
20.85
58.06
-37.21
-64.09%
Diluted Earnings per share
21.34
54.58
-33.24
-60.90%
Operating Profit Margin (Excl OI)
14.99%
24.89%
0.00
-9.90%
Gross Profit Margin
12.44%
30.37%
0.00
-17.93%
PAT Margin
10.87%
26.11%
0.00
-15.24%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 332.62 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 10.37% vs 8.26% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 39.62 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 13.10% vs 151.99% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.86 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 2.30% vs 31.09% in Mar 2023

Annual - Interest
Interest 9.11 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -9.98% vs -4.62% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.99%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023